|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
i have a life and its involves EXERCISE 
and other good habits, such as diet, and not taxing
the healthcare system by popping pills and laying
on the couch to loose weight. Please, if you are in
this stock for a buyout, do...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
9-Nov-09 08:15 pm |
| |
| 2. |
jerkjako is jealous
what's the matter, can't keep the debate to
the stock? bottom line is you know this is not a wise
investment
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
7-Nov-09 04:29 pm |
| |
| 3. |
are we headed to $4-5 first before $20?
barely up on strong days, down on neutral days and
really down on weak days, this does not seem to be
a good long term proposition.
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
6-Nov-09 09:31 pm |
| |
| 4. |
Re: Can you explain why...
i would not be invested in this obesity space at all.
most of the smart large institutions stayed away or
played verly little in obesity names. put simply.
..
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
6-Nov-09 09:20 pm |
| |
| 5. |
jerjacko has a better point
yeah, listen to jerkjacko instead of me...instead of
taking profits on a company that is going nowhere,
follow the pumper jerjacko and keep waiting for a
takeout which will NEVER happen. Let me...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
6-Nov-09 09:10 pm |
| |
| 6. |
don&&39;t be fooled by pumpers on this board
the company will burn through cash, sign a crappy partner
on crappy terms, or no partner at all, and revenues
will be under $400 M a year, for which OREX will recieve
if they are lucky 20%. sell into strength IMO
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
5-Nov-09 09:45 pm |
| |
| 7. |
$4-5 coming soon
no partner, no acquisition, no reimbursement, drip,
drip, drip
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
4-Nov-09 10:26 pm |
| |
| 8. |
Re: Tender offer for $40 coming soon
dont kid yourself, there's noone interested in
combination drugs for obesity. takeda signing with
AMLN should be the first sign
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
3-Nov-09 06:21 pm |
| |
| 9. |
going to $4-5 real soon
no partner coming folks, or no partner at least on
good terms. large pharma already took a look and passed
and you don't want a 30+ employee biotech detailing
an obesity drug...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
2-Nov-09 10:17 am |
| |
| 10. |
Potential partner passes on Contrave/Empatic
Look at AMLN news today. Takeda must have looked at
Contrave, empatic, qnexxa, lorcaserin and PASSED on
all 4 before choosing to partner with amylin Phase
2b. No partner will emerge for OREX/vvus/arna...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
2-Nov-09 06:00 am |
| |
| 11. |
going to $4-5 soon
going to $4-5 b/c no company wants to inlicense contrave
or empatic on reasonable terms b/c no third party
payer will reimburse obesity drugs with <10% placebo
subtracted weight loss.
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
30-Oct-09 09:32 pm |
| |
| 12. |
Timberrr $5 approaching soon
Weight loss is not sufficient enough for : 1) partners
of significant size to step in,and 2) third parties
to reimburse. end of story
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
28-Oct-09 08:33 pm |
| |
| 13. |
here&&39;s why this stock is going to $5 by Jan
Large pharma does not want to partner combination drugs
(patent risk)and they may have already passed on these
compounds, payers won't reimburse for anything
below...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Orexigen Therapeutics, Inc. (OREX)
|
|
jksnnh |
|
21-Oct-09 10:40 pm |
| |
| 14. |
Piper (tenthoff) is clueless
so let me get this, he has a SELL rating based only
on the thesis that we have balance sheet problems?
What mid-cap biotechnology company is not in need
of funding...
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Lexicon Pharmaceuticals, Inc. (LXRX)
|
|
jksnnh |
|
18-Oct-09 07:18 am |
| |